NCT Number: NCT05575908
Long-term sick leave is a challenge in Norway, and the healthcare and labor- and welfare services are often not coordinated in helping the sick-listed employees return to work. In this study, the investigators want to evaluate the effectiveness of an intervention where an expert team provides advice for an individualized patient pathway based on information from a digital questionnaire and a video meeting with the sick-listed employee and the participant's general practitioner. The patient pathway should include both healthcare and labor- and welfare services measures.
Sick-listed patients with musculoskeletal- and/or common mental disorders are invited to join the study. They will receive a digital questionnaire and be randomized to either treatment as usual or personalized advice from an expert team. The team will be put together based on the response from the individual's questionnaire.
The investigators will evaluate the effect on return to work and the use of health care services 12 months after the intervention.
This study is active but is not currently recruiting participants.
18 year–60 year
All sexes
Interventional
Not applicable
Sykehuset Levanger, Levanger, Midt-Norge, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A digital team will be appointed based on the participant's answers in the digital screening questionnaire. Members of the team can be specialists in Physical and rehabilitation medicine, psychologist, physiotherapist, social workers, and consultants in the labor- and welfare administration. The general practitioner will also be invited to the meeting.
Time frame: 12 months
Time to return to work within 12 months for at least 4 consecutive weeks
Time frame: 12 months
Approvement in function measured by Versus Arthritis Musculoskeletal Health Questionnaire (MSK-HQ). The MSK-HQ is scored on a range of 0-56, with a better score indicating better MSK-HQ health status
Time frame: 12 months
Change in pain measured on a numeric rating scale (0-10), with a higher score indicating more pain
Time frame: 12 months
Improvement in depression symptoms measured by Patient Health Questionnaire-9 (PHQ-9). PHQ-9 is scored on a range of 0-27, with higher score indicating more serious symptoms
Time frame: 12 months
Improvement in anxiety symptoms measured by Generalized Anxiety Disorder 7-item (GAD-7). GAD-7 is scored on a range of 0-21, with higher score indicating more serious symptoms
Time frame: 12 months
Lost workdays during one year after intervention
Time frame: 12 months
Prevalence of insomnia and bad sleep quality and change after 12 months. Measured with Insomnia severity index (ISI). ISI is scored on a range from 0-4, with higher score indicating more serious symptoms.
St. Olavs Hospital
Other
Acronym: Expert@Work
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05450406
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT02541890
Chronic Disease, Disease Attributes
Trondheim, Norway
View Trial DetailsNCT06550024
Arthritis, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05844124
Arthritis, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial Details